Journal of Orthopaedic Translation · Nov 2026

Establishment and comparative analysis of etiologically distinct mouse models reveal heterogeneity in early osteoarthritis pathogenesis

By Xu H, Ding G, Zhang X et al.

Background Osteoarthritis (OA) is a highly heterogeneous disease, yet drug discovery continues to be bottlenecked by a historical "homotherapy for heteropathy" approach. While clinical sample-based studies have successfully identified distinct molecular endotypes, the unique early-stage pathogenesis for each remains unresolved. Methods To investigate early-stage heterogeneity across four clinical OA risk factors, mouse models were established via high-fat diet (HFD) feeding, natural aging, mechanical overload, and surgical trauma with superimposed abnormal loading (trauma). We performed multi-tissue histology, high-field magnetic resonance imaging (MRI), and immunofluorescence, alongside time-series transcriptomic profiling of chondrocytes to map early-stage molecular signatures. Results We constructed four mouse models recapitulating the major clinical risk factors of OA, which exhibited distinct early-stage tissue vulnerabilities. The HFD model initiated with isolated meniscal ossification, whereas the trauma model presented with rapid subchondral bone resorption and unique tibial bone marrow lesions (BMLs). Lipid accumulation, p16-mediated senescence, and p65 inflammatory activation were preferentially elicited early in an etiology-specific manner. Transcriptomic profiling and in vivo validation identified unique early-response signaling modules: HFD and palmitic acid upregulated PPAR signaling; aging and hydrogen peroxide triggered MAPK/ERK signaling; mechanical overload activated focal adhesion cascades; and trauma stimulated inflammatory networks. Conclusions The construction of animal models allows for a systematic comparison and understanding of OA heterogeneity, uncovering distinct pathological traits and molecular mechanisms across different risk factors. These model-derived insights lay a mechanistic foundation for identifying endotype-specific therapeutic targets. Translational potential This study established animal models recapitulating major clinical risk factors for OA, thereby providing a reliable experimental platform for the precision subclassification of heterogeneous OA. The etiology-specific pathological feature and molecular mechanism identified in these models offer quantifiable phenotypic and molecular evidence for targeted drug screening across OA endotypes. Importantly, they also lay a mechanistic foundation for the discovery of novel therapeutic targets. Together, this work builds a translational bridge from clinical endotyping to etiology-driven therapy, advancing the clinical implementation of precision medicine in OA.

doi.org/10.1016/j.jot.2026.101266Open accessMechanisms

AgingResearch.News